SALE EXTENDED
MarketBeat All Access
Start your 30-day free trial,
then continue your subscription for 50% off.
TODAY ONLY!
Claim Your Discount
×
S&P 500   3,639.66 (-2.80%)
DOW   29,296.79 (-2.11%)
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
S&P 500   3,639.66 (-2.80%)
DOW   29,296.79 (-2.11%)
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
S&P 500   3,639.66 (-2.80%)
DOW   29,296.79 (-2.11%)
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
S&P 500   3,639.66 (-2.80%)
DOW   29,296.79 (-2.11%)
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
NASDAQ:PGEN

Precigen - PGEN Earnings Date, Estimates & Call Transcripts

$1.76
-0.30 (-14.56%)
(As of 10/7/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.76
$2.05
50-Day Range
$2.02
$2.79
52-Week Range
$1.12
$5.60
Volume
1.41 million shs
Average Volume
1.50 million shs
Market Capitalization
$366.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.50

Earnings Summary

Upcoming
Earnings Date
Nov. 14Estimated
Actual EPS
(Aug. 8)
-$0.13 Beat By $0.03
Consensus EPS
(Aug. 8)
-$0.16
Last Year's Q3 EPS
(8/9/2021)
-$0.10
Skip Charts & View Estimated and Actual Earnings Data

PGEN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PGEN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Precigen Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20221($0.10)($0.10)($0.10)
Q2 20221($0.10)($0.10)($0.10)
Q3 20221($0.11)($0.11)($0.11)
Q4 20221($0.11)($0.11)($0.11)
FY 20224($0.42)($0.42)($0.42)

PGEN Earnings Date and Information

Precigen last released its quarterly earnings results on August 8th, 2022. The biotechnology company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.03. The company earned $2.91 million during the quarter, compared to the consensus estimate of $17.55 million. Precigen has generated ($0.47) earnings per share over the last year (($0.47) diluted earnings per share). Earnings for Precigen are expected to decrease in the coming year, from ($0.07) to ($0.56) per share. Precigen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 14th, 2022 based off prior year's report dates.

Precigen Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/14/2022
(Estimated)
        
8/8/2022Q2 2022($0.16)($0.13)+$0.03($0.17)$17.55 million$2.91 million    
8/8/2022Q2 2022($0.16)($0.13)+$0.03($0.17)$17.55 million$2.91 million    
5/9/2022Q1 2022($0.14)($0.10)+$0.04($0.10)$20.90 million$32.02 million
5/9/2022Q1 2022($0.14)($0.10)+$0.04($0.10)$20.90 million$32.02 million
3/1/2022Q4 2021($0.14)($0.13)+$0.01($0.13)$21.13 million$24.22 million
3/1/2022Q4 2021($0.14)($0.13)+$0.01($0.13)$21.13 million$24.22 million
11/8/2021Q3 2021($0.14)($0.15)($0.01)($0.15)$24.47 million$21.56 million
11/8/2021Q3($0.1420)($0.15)($0.0080)($0.15)$24.47 million$21.56 million
8/9/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$22.48 million$33.58 million
8/9/20216/30/2021($0.12)($0.10)+$0.02($0.10)$22.48 million$33.58 million    
5/10/2021Q1 2021($0.16)($0.11)+$0.05($0.13)$19.85 million$24.51 million
5/10/2021Q1 2021($0.16)($0.11)+$0.05($0.13)$19.85 million$24.51 million  
3/1/2021Q4 2020($0.16)($0.11)+$0.05$0.01$23.05 million$19.33 million
2/28/202112/31/2020($0.17)($0.23)($0.06)$0.01$23.05 million$19.33 million  
11/9/2020Q3 2020($0.11)($0.12)($0.01)($0.06)$20.58 million$23.58 million
11/9/20209/30/2020($0.14)($0.18)($0.04)($0.06)$20.58 million$23.58 million    
8/10/2020Q2 2020($0.03)($0.07)($0.04)$0.12$20.27 million$30.42 million
8/10/20206/30/2020($0.03)($0.07)($0.04)$0.12$20.27 million$30.42 million    
5/6/2020Q1 2020($0.19)($0.19)($0.03)$29.84 million
5/6/2020Q1 2020($0.19)($0.19)($0.03)$29.84 million
3/2/2020Q4 2019($0.25)($0.25)$0.59$24.17 million$17.00 million
3/2/2020Q4 2019($0.25)($0.25)$0.59$24.17 million$17.00 million
11/12/2019Q3 2019($0.24)($0.22)+$0.02($0.09)$32.16 million$23.04 million
11/12/2019Q3 2019($0.24)($0.22)+$0.02($0.09)$32.16 million$23.04 million  
11/12/2019Q3 2019($0.24)($0.22)+$0.02($0.09)$32.16 million$23.04 million  
8/8/2019Q2 2019($0.26)($0.21)+$0.05($0.17)$37.00 million$35.99 million
8/8/2019Q2 2019($0.26)($0.21)+$0.05($0.17)$37.00 million$35.99 million  
8/8/2019Q2 2019($0.30)($0.25)+$0.05($0.17)$29.62 million$35.99 million    
5/9/2019Q1 2019($0.28)($0.28)($0.16)$35.26 million$23.34 million
5/9/2019Q1 2019($0.28)($0.28)($0.16)$35.26 million$23.34 million  
5/9/20193/31/2019($0.28)($0.28)($0.16)$32.12 million$23.30 million  
2/28/2019Q4 2018($0.37)($0.23)+$0.14$2.13$61.81 million$43.19 million
2/28/2019Q4 2018($0.37)($0.23)+$0.14$2.13$61.81 million$43.19 million  
2/28/2019Q4 2018($0.37)($0.23)+$0.14$2.13$61.81 million$43.19 million  
11/8/2018Q3 2018($0.23)($0.14)+$0.09$0.16$42.80 million$32.45 million
11/8/2018Q3 2018($0.23)($0.14)+$0.09$0.16$42.80 million$32.45 million  
11/8/20189/30/2018($0.23)($0.44)($0.21)$0.16$35.98 million$32.45 million    
8/9/2018Q2 2018($0.23)($0.24)($0.01)$0.03$53.07 million$45.30 million
8/9/2018Q2 2018($0.23)($0.24)($0.01)$0.03$53.07 million$45.30 million  
8/9/2018Q2 2018($0.23)($0.51)($0.28)$0.03$51.70 million$45.30 million  
5/10/2018Q1 2018($0.24)($0.17)+$0.07($0.01)$55.29 million$43.84 million
5/10/2018Q1 2018($0.24)($0.17)+$0.07($0.01)$55.29 million$43.84 million  
5/10/2018Q1 2018($0.24)($0.33)($0.09)($0.01)$60.43 million$43.80 million  
3/1/2018Q4 2017($0.31)($0.17)+$0.14($0.11)$48.79 million$77.03 million
3/1/2018Q4 2017($0.31)($0.17)+$0.14($0.11)$48.79 million$77.03 million
3/1/2018Q4 2017($0.31)($0.23)+$0.08($0.11)$48.16 million$77.03 million  
11/9/2017Q3 2017($0.22)($0.20)+$0.02($0.07)$55.17 million$46.02 million
11/9/2017Q3 2017($0.22)($0.20)+$0.02($0.07)$55.17 million$46.02 million
11/9/2017Q3 2017($0.22)($0.20)+$0.02($0.07)$55.17 million$46.02 million
8/9/2017Q2 2017($0.21)($0.16)+$0.05($0.16)$56.97 million$54.43 million
8/9/2017Q2 2017($0.21)($0.16)+$0.05($0.16)$56.97 million$54.43 million
8/9/2017Q2 2017($0.21)($0.16)+$0.05($0.16)$57.17 million$54.40 million  
5/10/2017Q1 2017($0.23)($0.26)($0.03)($0.26)$48.79 million$53.75 million
5/10/2017Q1 2017($0.23)($0.26)($0.03)($0.26)$48.79 million$53.75 million
5/10/2017Q1 2017($0.22)($0.26)($0.04)($0.26)$49.08 million$53.70 million
3/1/2017Q4 2016($0.23)($0.26)($0.03)($0.15)$52.39 million$46.00 million
3/1/2017Q4 2016($0.23)($0.26)($0.03)($0.15)$52.39 million$46.00 million
3/1/2017Q4 2016($0.23)($0.26)($0.03)($0.15)$52.53 million$46.00 million  
11/9/2016Q3 2016($0.24)($0.24)($0.24)$49.72 million$48.99 million
11/9/2016Q3 2016($0.24)($0.24)($0.24)$49.72 million$48.99 million
11/9/2016Q3 2016($0.24)($0.24)($0.24)$51.70 million$48.99 million  
8/9/2016Q2 2016($0.23)($0.29)($0.06)($0.16)$55.37 million$52.50 million
8/9/2016Q2 2016($0.23)($0.29)($0.06)($0.16)$55.37 million$52.50 million
8/9/2016Q2 2016($0.23)($0.29)($0.06)($0.16)$53.78 million$52.50 million
5/10/2016Q1 2016($0.29)($0.32)($0.03)($0.09)$44.45 million$43.44 million
5/10/2016Q1 2016($0.29)($0.32)($0.03)($0.09)$44.45 million$43.44 million
5/10/2016Q1 2016($0.29)($0.32)($0.03)($0.09)$46.26 million$43.40 million  
2/29/2016Q4 2015($0.18)($0.17)+$0.01($0.06)$41.04 million$41.50 million
2/29/2016Q4 2015($0.18)($0.17)+$0.01($0.06)$41.04 million$41.50 million
2/29/2016Q4 2015($0.18)($0.17)+$0.01($0.06)$41.82 million$41.50 million  
11/9/2015Q3 2015($0.25)($0.34)($0.09)($0.34)$39.74 million$53.37 million
11/9/2015Q3 2015($0.25)($0.34)($0.09)($0.34)$39.74 million$53.37 million
11/9/2015Q3 2015($0.25)($0.34)($0.09)($0.34)$40.84 million$53.40 million
8/10/2015Q2 2015($0.13)($0.25)($0.12)($0.13)$46.25 million$44.89 million
8/10/2015Q2 2015($0.13)($0.25)($0.12)($0.13)$46.25 million$44.89 million
8/10/2015Q2 2015($0.13)($0.25)($0.12)($0.13)$55.93 million$44.90 million  
5/11/2015Q1 2015($0.01)$0.25+$0.26$0.25$31.30 million$33.85 million
5/11/2015Q1 2015($0.01)$0.25+$0.26$0.25$31.30 million$33.85 million
5/11/2015Q1 2015($0.01)$0.25+$0.26$0.25$32.90 million$33.80 million  
3/2/2015Q4 2014($0.19)$0.18+$0.37$0.18$22.52 million$31.09 million
3/2/2015Q4 2014($0.19)$0.18+$0.37$0.18$22.52 million$31.09 million
3/2/2015Q4 2014($0.19)$0.18+$0.37$0.18$26.11 million$31.10 million
11/13/2014Q3 2014($0.29)($0.24)+$0.05$0.05$18.25 million$21.20 million
11/13/2014Q3 2014($0.29)($0.24)+$0.05$0.05$18.25 million$21.20 million
11/13/2014Q3 2014($0.29)($0.24)+$0.05$0.05$19.40 million$21.20 million
8/14/2014Q2 2014($0.20)($0.31)($0.11)($0.09)$8.09 million$11.79 million
8/14/2014Q2 2014($0.20)($0.31)($0.11)($0.09)$8.09 million$11.79 million
8/14/2014Q2 2014($0.20)($0.31)($0.11)($0.09)$9.39 million$11.80 million  
5/7/2014Q1 2014($0.09)($0.10)($0.01)($0.24)$11.25 million$7.85 million
5/7/2014Q1 2014($0.09)($0.10)($0.01)($0.24)$11.25 million$7.85 million
5/7/2014Q1 2014($0.09)($0.10)($0.01)($0.24)$11.25 million$7.90 million
3/31/2014Q4 2013($0.08)($0.13)($0.05)($0.13)$8.52 million$7.14 million
3/31/2014Q4 2013($0.08)($0.13)($0.05)($0.13)$8.52 million$7.14 million
3/31/2014Q4 2013($0.08)($0.13)($0.05)($0.13)$8.38 million$7.10 million
11/7/2013Q3 2013($0.01)$0.15+$0.16$0.15$10.49 million$6.13 million
11/7/2013Q3 2013($0.01)$0.15+$0.16$0.15$10.49 million$6.13 million
11/7/2013Q3 2013($0.01)$0.15+$0.16$0.15$9.79 million$6.10 million
9/19/2013Q2 2013$0.09($0.17)($0.26)($0.17)$22.00 million$6.78 million
9/19/2013Q2 2013$0.09($0.17)($0.26)($0.17)$22.00 million$6.78 million
9/19/2013Q2 2013$0.09($0.17)($0.26)($0.17)$22.00 million$6.78 million












Precigen Earnings - Frequently Asked Questions

When is Precigen's earnings date?

Precigen has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 14th, 2022 based off last year's report dates. Learn more on PGEN's earnings history.

Did Precigen beat their earnings estimates last quarter?

In the previous quarter, Precigen (NASDAQ:PGEN) reported ($0.13) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.16) by $0.03. Learn more on analysts' earnings estimate vs. PGEN's actual earnings.

How can I listen to Precigen's earnings conference call?

The conference call for Precigen's latest earnings report can be listened to online. Listen to Conference Call

How can I read Precigen's conference call transcript?

The conference call transcript for Precigen's latest earnings report can be read online. Read Transcript

How much revenue does Precigen generate each year?

Precigen (NASDAQ:PGEN) has a recorded annual revenue of $103.87 million.

How much profit does Precigen generate each year?

Precigen (NASDAQ:PGEN) has a recorded net income of -$92.17 million. PGEN has generated -$0.47 earnings per share over the last four quarters.

What is Precigen's EPS forecast for next year?

Precigen's earnings are expected to decrease from ($0.07) per share to ($0.56) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:PGEN) was last updated on 10/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.